1384PDSUNitinib with EVOfosfamide (TH-302) for G1/G2 metastatic pancreatic neuroendocrine tumours (pNETs) naïve for systemic treatment. The SUNEVO phase II trial of the Spanish task force group for neuroendocrine and endocrine tumours (GETNE)
Grande, E, Lopez, C, Alonso Gordoa, T, Benavent, M, Capdevila, J, Teulé, A, Custodio, A, Sevilla, I, Gajate, P, Molina-Cerrillo, J, Hernando Cubero, J, Garcia-Carbonero, RVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz256.004
Date:
October, 2019
File:
PDF, 85 KB
2019
File converter
More search results
More benefits 
